| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |